open access

Vol 95, No 1 (2024)
Research paper
Published online: 2023-07-11
Get Citation

Recurrent cervical adenofibroma progressing to adenosarcoma: a rare case report

Li Chen1, Yugang Chi1, Yanlin Chen12
·
Pubmed: 37435916
·
Ginekol Pol 2024;95(1):4-7.
Affiliations
  1. Department of Obstetrics and Gynecology,Women and Children’s Hospital of Chongqing Medical University, (Chongqing Health Center for Women and Children),Chongqing, People's Republic of China
  2. Department of Pathology,Women and Children’s Hospital of Chongqing Medical University (Chongqing Health Center for Women and Children),Chongqing, People's Republic of China

open access

Vol 95, No 1 (2024)
ORIGINAL PAPERS Gynecology
Published online: 2023-07-11

Abstract

Objectives: Cervical adenofibroma is a rare form of mixed mesodermal tumor that can present as cervical polyps with
a tendency for local recurrence and progression. Few cases progressing to adenosarcoma have previously been reported.
We report a case of cervical adenofibroma progressing to adenosarcoma, and we seek to remind clinicians of the method
and importance of the differential diagnosis of this disease.
Material and methods: A fertile woman was admitted in our department for the eighth recurrence of a cervical polypoidal
mass which for the past 10 years. Recurrence of cervical adenofibroma was confirmed by ultrasound and MRI. A wide
local excision under hysteroscopy was performed due to her strong desire to preserve the uterus.
Results: Surgical pathology and immunohistochemical interpretation revealed cervical adenosarcoma. A hysterectomy
with conservation of the ovaries was recommended, with regular follow-ups for evidence of disease recurrence.
Conclusions: Differential diagnoses of cervical adenofibroma are hard to prove. Adenosarcoma should be ruled out,
especially in women presenting with recurrent cervical polypoidal masses. A combined histological/immunohistochemical
investigation is mandatory.

Abstract

Objectives: Cervical adenofibroma is a rare form of mixed mesodermal tumor that can present as cervical polyps with
a tendency for local recurrence and progression. Few cases progressing to adenosarcoma have previously been reported.
We report a case of cervical adenofibroma progressing to adenosarcoma, and we seek to remind clinicians of the method
and importance of the differential diagnosis of this disease.
Material and methods: A fertile woman was admitted in our department for the eighth recurrence of a cervical polypoidal
mass which for the past 10 years. Recurrence of cervical adenofibroma was confirmed by ultrasound and MRI. A wide
local excision under hysteroscopy was performed due to her strong desire to preserve the uterus.
Results: Surgical pathology and immunohistochemical interpretation revealed cervical adenosarcoma. A hysterectomy
with conservation of the ovaries was recommended, with regular follow-ups for evidence of disease recurrence.
Conclusions: Differential diagnoses of cervical adenofibroma are hard to prove. Adenosarcoma should be ruled out,
especially in women presenting with recurrent cervical polypoidal masses. A combined histological/immunohistochemical
investigation is mandatory.

Get Citation

Keywords

cervical adenofibroma; adenosarcoma; recurrence; histological/immunohistochemical investigation

About this article
Title

Recurrent cervical adenofibroma progressing to adenosarcoma: a rare case report

Journal

Ginekologia Polska

Issue

Vol 95, No 1 (2024)

Article type

Research paper

Pages

4-7

Published online

2023-07-11

Page views

533

Article views/downloads

324

DOI

10.5603/GP.a2023.0069

Pubmed

37435916

Bibliographic record

Ginekol Pol 2024;95(1):4-7.

Keywords

cervical adenofibroma
adenosarcoma
recurrence
histological/immunohistochemical investigation

Authors

Li Chen
Yugang Chi
Yanlin Chen

References (14)
  1. Abell MR. Papillary adenofibroma of the uterine cervix. Am J Obstet Gynecol. 1971; 110(7): 990–993.
  2. D'Angelo E, Prat J. Pathology of mixed Müllerian tumours. Best Pract Res Clin Obstet Gynaecol. 2011; 25(6): 705–718.
  3. Mikami S, Kikunaga H, Kameyama K, et al. Clear cell adenocarcinoma arising in endometrial adenofibroma. Pathol Int. 2011; 61(3): 167–170.
  4. Oh J, Park SB, Han BH, et al. Imaging Features of Carcinosarcoma Arising from Adenofibroma of the Uterus: A Case Report. Curr Med Imaging. 2020; 16(8): 1048–1051.
  5. Arend R, Bagaria M, Lewin SN, et al. Long-term outcome and natural history of uterine adenosarcomas. Gynecol Oncol. 2010; 119(2): 305–308.
  6. Lugo Santiago N, Groth J, Hussain N, et al. Management and survival of patients with Mullerian adenosarcoma of the cervix without sarcomatous overgrowth desiring fertility preservation, a case report and review of the literature. Gynecol Oncol Rep. 2020; 32: 100525.
  7. Li BB, Zheng YH, Chen QY, et al. Cervical adenofibroma without clinical symptoms: report of a rare case. J Int Med Res. 2022; 50(9): 3000605221125525.
  8. Zhu X, Peng C, Huang Y, et al. Uterine cervical Müllerian adenosarcoma possibly arising from ovarian cystadenofibroma: A case report and review of the literature. Front Oncol. 2022; 12: 1064851.
  9. Chin PS, Chia YN, Lim YK, et al. Diagnosis and management of Müllerian adenosarcoma of the uterine cervix. Int J Gynaecol Obstet. 2013; 121(3): 229–232.
  10. Seltzer VL, Levine A, Spiegel G, et al. Adenofibroma of the uterus: multiple recurrences following wide local excision. Gynecol Oncol. 1990; 37(3): 427–431.
  11. Navada HM, Bhat BP, Ramani G, et al. Unusual presentation of rare case of papillary adenofibroma of cervix in a young woman. Case Rep Oncol Med. 2012; 2012: 914642.
  12. Chu IL, Chen CL, Hsu CS. Adenofibroma of the uterine cervix coexistent with endometriosis. Taiwan J Obstet Gynecol. 2012; 51(2): 285–288.
  13. Seagle BLL, Kanis M, Strohl AE, et al. Survival of women with Mullerian adenosarcoma: A National Cancer Data Base study. Gynecol Oncol. 2016; 143(3): 636–641.
  14. Zhu X, Peng C, Huang Y, et al. Uterine cervical Müllerian adenosarcoma possibly arising from ovarian cystadenofibroma: A case report and review of the literature. Front Oncol. 2022; 12: 1064851.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl